Athira Pharma, Inc. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Athira Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Athira Pharma, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$28M, a 11.4% increase year-over-year.
  • Athira Pharma, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$120M, a 1.1% decline year-over-year.
  • Athira Pharma, Inc. annual Operating Income (Loss) for 2023 was -$125M, a 20.6% decline from 2022.
  • Athira Pharma, Inc. annual Operating Income (Loss) for 2022 was -$104M, a 62.5% decline from 2021.
  • Athira Pharma, Inc. annual Operating Income (Loss) for 2021 was -$64M, a 220% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$125M -$21.5M -20.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 -$104M -$40M -62.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 -$64M -$44M -220% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 -$20M -$14.5M -267% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 -$5.45M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.